DR. RAVI VENKATA DURVASULA, MD
Osteopathic Medicine at University Of New Mexico, Albuquerque, NM
License number
New Mexico 032619
Category
Osteopathic Medicine
Type
Infectious Disease
License number
New Mexico MD2014-0789
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
1 University Of New Mexico, Albuquerque, NM 87131
Phone
(505) 272-5666
(505) 272-4435 (Fax)
(505) 362-0856
(505) 272-4435 (Fax)
(505) 362-0856
Professional information
Ravi Venkata Durvasula, Albuquerque NM
Specialties:
Internist
Address:
1501 San Pedro Dr Se, Albuquerque, NM 87108
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Ravi V Durvasula, Albuquerque NM - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
1501 San Pedro Dr SE, Albuquerque 87108
(505) 265-1711 (Phone), (505) 256-2803 (Fax)
(505) 265-1711 (Phone), (505) 256-2803 (Fax)
Certifications:
Internal Medicine, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
McGill University / Faculty of Medicine
McGill University / Faculty of Medicine
Methods And Compositions For Control Of Disease In Aquaculture
US Patent:
2008010, May 8, 2008
Filed:
Aug 17, 2007
Appl. No.:
11/893699
Inventors:
Ravi Durvasula - Albuquerque NM, US
Subba Durvasula - Darthmouth, CA
Subba Durvasula - Darthmouth, CA
International Classification:
A61K 35/66, A61K 39/00, A61K 39/395, A61K 31/70, A61P 43/00
US Classification:
424135100, 424093200, 424184100, 514044000, 424164100, 424159100
Abstract:
The invention discloses paratransgenesis methods for prevention, amelioration or treatment of a disease or disorder in an aquatic animal. The method comprises providing a genetically modified micro algae that expresses a recombinant molecule that specifically targets one or more key epitopes of a pathogen that infects the aquatic animal and ii) feeding the aquatic animal directly or indirectly with the genetically modified unicellular algae.
Fluorescent Fusion Polypeptides And Methods Of Use
US Patent:
2011026, Nov 3, 2011
Filed:
Apr 28, 2011
Appl. No.:
13/096695
Inventors:
ANATOLIY MARKIV - Brentford, GB
Ravi Venkata Durvasula - Albuquerque NM, US
Angray Singh Kang - Leyton, GB
Ravi Venkata Durvasula - Albuquerque NM, US
Angray Singh Kang - Leyton, GB
International Classification:
A61K 49/00, C07H 21/00, C12N 5/09, C12N 1/00, C12P 21/02, C12Q 1/04, G01N 33/53, C12Q 1/02, G01N 33/543, C07K 19/00, C12N 15/85
US Classification:
424 96, 5303873, 536 234, 435325, 435243, 435455, 435 34, 435 71, 435 72, 435 29, 436501, 435 696
Abstract:
Embodiments of the present invention provide for the facile generation of a stable recombinant fusion polypeptides with intrinsic fluorescent properties. The recombinant antibodies may be suitable for qualitative and/or quantitative immunofluorescence analysis. Generally, the fluorescent polypeptides include a fluorescent domain comprising a C-terminus and an N-terminus; a first antibody domain covalently linked to the C-terminus; and a second antibody domain covalently linked to the N-terminus.
Methods And Compositions For Control Of Disease In Aquaculture
US Patent:
2011015, Jun 30, 2011
Filed:
Apr 2, 2010
Appl. No.:
12/753400
Inventors:
Ravi Durvasula - Albuquerque NM, US
Subba Durvasula - Darthmouth, CA
Subba Durvasula - Darthmouth, CA
International Classification:
A61K 36/02, A01K 61/00
US Classification:
424 932, 119212
Abstract:
The invention discloses paratransgenesis methods for prevention, amelioration and/or treatment of a disease or disorder in an aquatic animal. The method comprises providing a genetically modified micro algae that expresses a recombinant molecule that specifically targets one or more key epitopes of a pathogen that infects the aquatic animal and ii) feeding the aquatic animal directly or indirectly with the genetically modified unicellular algae.